MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30001419.
- Also identified by DOI 10.1371/journal.pone.0200540 and PMC identifier 6042767.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Major histocompatibility complex class II (MHC II) expression and turn-over are regulated via its ubiquitination by the membrane associated RING-CH 1 (MARCH1) E3 ligase. Unexpectedly, we show that MHC II ubiquitination also impacts MHC I. Lack of MARCH1 in B cells and dendritic cells (DCs) resulted in a significant reduction in surface MHC I expression. This decrease was not directly caused by changes in MARCH1 ubiquitination of MHC I but indirectly by altered MHC II trafficking in the absence of its ubiquitination. Deletion of MHC II in March1-/- cells restored normal MHC I surface expression and replacement of wild type MHC II by a variant that could not be ubiquitinated caused a reduction in MHC I expression. Furthermore, these cells displayed inefficient presentation of peptide and protein antigen via MHC I to CD8+ T cells. In summary, we describe an unexpected intersection between MHC I and MHC II such that the surface expression of both molecules are indirectly and directly regulated by MARCH1 ubiquitination, respectively.
Medical subject headings
- Antigen Presentation
- B-Lymphocytes
- CD8-Positive T-Lymphocytes
- Dendritic Cells
- Histocompatibility Antigens Class I
- Histocompatibility Antigens Class II
- Ubiquitin-Protein Ligases
- Ubiquitination